Literature DB >> 16850150

Minimally invasive esophagectomy for cancer: prospective evaluation of laparoscopic gastric mobilization.

Gaelle Godiris-Petit1, Nicolas Munoz-Bongrand, Isabelle Honigman, Pierre Cattan, Emile Sarfati.   

Abstract

BACKGROUND: Esophagectomy carries high morbidity, mainly respiratory. Minimally invasive surgery has been demonstrated to improve postoperative outcome in digestive surgery, without impairment of oncological results. A prospective study was conducted to evaluate feasibility, postoperative outcome, and mid-term oncological results of minimally invasive esophagectomy (MIE) in cancer.
METHODS: From July 2001 to August 2005, 25 patients underwent esophagectomy with laparoscopic gastric mobilization (LGM) for epidermoid carcinoma (n=15) or adenocarcinoma (n=10). Tumors were located on the cardia (n=6), on the lower third (n=14), or on the median third (n=5) of the esophagus. Following LGM, transthoracic esophagectomy was performed.
RESULTS: Complete LGM was achieved in all patients but 1. Mean operative time for LGM was 191+/-49 minutes. Fifteen patients (60%) developed complications, mainly respiratory. Anastomotic leakage occurred in 2 patients, with a favorable outcome. Pylorospasm (n=1) was the only intra-abdominal complication. Median hospital stay was 18 days. Two patients died (8%). Twenty-three patients underwent R0 resection. A mean of 12+/-4 lymph nodes (range 4-19 nodes) were analyzed. With a mean follow-up of 14 months (1-46 months), actuarial survival at 1 and 2 years was, respectively, 73% and 56%.
CONCLUSION: Esophagectomy with LGM is feasible with few specific complications. However, no decrease in morbidity and hospital stay could be observed. Mid-term oncological results seem comparable to those of conventional surgery. Further studies are required to evaluate the extent of lymphadenectomy and the oncologic safety of MIE.

Entities:  

Mesh:

Year:  2006        PMID: 16850150     DOI: 10.1007/s00268-005-0627-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.

Authors:  Jeffrey Rentz; David Bull; David Harpole; Stephen Bailey; Leigh Neumayer; Theodore Pappas; Barbara Krasnicka; William Henderson; Jennifer Daley; Shukri Khuri
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

2.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

Review 3.  Port site metastases.

Authors:  Myriam J Curet
Journal:  Am J Surg       Date:  2004-06       Impact factor: 2.565

4.  Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction.

Authors:  S Gabor; H Renner; V Matzi; B Ratzenhofer; J Lindenmann; O Sankin; H Pinter; A Maier; J Smolle; F M Smolle-Jüttner
Journal:  Br J Nutr       Date:  2005-04       Impact factor: 3.718

5.  Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis.

Authors:  J B Hulscher; J G Tijssen; H Obertop; J J van Lanschot
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

6.  Analysis of reduced death and complication rates after esophageal resection.

Authors:  B P Whooley; S Law; S C Murthy; A Alexandrou; J Wong
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

7.  Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy.

Authors:  N T Nguyen; D M Follette; B M Wolfe; P D Schneider; P Roberts; J E Goodnight
Journal:  Arch Surg       Date:  2000-08

8.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

9.  Role of videoassisted surgery in the treatment of oesophageal cancer.

Authors:  J M Collard
Journal:  Ann Chir Gynaecol       Date:  1995

Review 10.  Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.

Authors:  Christophe Mariette; Guillaume Taillier; Isabelle Van Seuningen; Jean-Pierre Triboulet
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

View more
  6 in total

Review 1.  Minimally invasive oesophagectomy: current status and future direction.

Authors:  Nick Butler; Stuart Collins; Breda Memon; Muhammed Ashraf Memon
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

2.  Two-phase laparoscopic-assisted oesophago-gastrectomy: a single-unit experience of 111 consecutive cases and outcomes.

Authors:  Cara R Baker; Michael E Bailey; Yuen Soon; Sukhpal Singh; Shaun R Preston
Journal:  Surg Endosc       Date:  2011-06-08       Impact factor: 4.584

3.  Open versus minimally invasive esophagectomy: a single-center case controlled study.

Authors:  Sebastian F Schoppmann; Gerhard Prager; Felix B Langer; Franz M Riegler; Barbara Kabon; Edith Fleischmann; Johannes Zacherl
Journal:  Surg Endosc       Date:  2010-05-13       Impact factor: 4.584

4.  Total laparoscopic gastric mobilization for esophagectomy.

Authors:  Hiroyuki Kitagawa; Toyokazu Akimori; Takehiro Okabayashi; Tsutomu Namikawa; Tekeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2008-06-10       Impact factor: 3.445

5.  Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer.

Authors:  J Christian Cash; Joerg Zehetner; Bobak Hedayati; Nikolai A Bildzukewicz; Namir Katkhouda; Rodney J Mason; John C Lipham
Journal:  Surg Endosc       Date:  2013-10-08       Impact factor: 4.584

6.  Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.

Authors:  Nicolas Briez; Guillaume Piessen; Franck Bonnetain; Cécile Brigand; Nicolas Carrere; Denis Collet; Christophe Doddoli; Renaud Flamein; Jean-Yves Mabrut; Bernard Meunier; Simon Msika; Thierry Perniceni; Frédérique Peschaud; Michel Prudhomme; Jean-Pierre Triboulet; Christophe Mariette
Journal:  BMC Cancer       Date:  2011-07-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.